The European medicines agency review of abiraterone for the treatment of metastatic castration-resistant prostate cancer in adult men after docetaxel chemotherapy and in chemotherapy-naïve disease: Summary of the scientific assessment of the committee for medicinal products for human use

1. Gravanis, I.
2. Sancho Lopez, A.
3. Hemmings, R.J.
4. Camarero Jiménez, J.
5. Garcia-Carbonero, R.
6. García Gallego, I.
7. Valencia Giménez, E.
8. O'Connor, D.
9. Giuliani, R.
10. Salmonson, T.
11. Pignatti, F.